Pharmacogenetics in reproductive and perinatal medicine

被引:12
作者
Alfirevic, Ana [1 ]
Alfirevic, Zarko [2 ]
Pirmohamed, Munir [1 ]
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
[2] Liverpool Womens Hosp, Liverpool, Merseyside, England
关键词
obstetrics; perinatal; pharmacogenetics; polymorphisms; reproduction; NEURAL-TUBE DEFECTS; DIHYDROFOLATE-REDUCTASE DHFR; STIMULATING-HORMONE RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; STEVENS-JOHNSON-SYNDROME; ONE-CARBON METABOLISM; FACTOR-V-LEIDEN; BREAST-CANCER; FOLIC-ACID; BETA-2-ADRENERGIC RECEPTOR;
D O I
10.2217/PGS.09.153
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The clinical application of pharmacogenetics has been well accepted by some medical specialties, but not all. The aim of this review is to discuss the current use of pharmacogenetics in reproductive and perinatal medicine and to highlight areas where pharmacogenetics may be able to help in the future to predict response to medicines in terms of efficacy and safety. This applies to drugs that are specific to pregnancy and reproduction, as well as drugs prescribed for the treatment of medical disorders in pregnancy. Our review points out the need for well-designed clinical studies on the efficacy and safety of medicines used in women of childbearing age in order to define the additional utility provided by pharmacogenetic testing.
引用
收藏
页码:65 / 79
页数:15
相关论文
共 159 条
[1]  
Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741
[2]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[3]   HLA-B locus in Caucasian patients with carbamazepine hypersensitivity [J].
Alfirevic, Ana ;
Jorgensen, Andrea L. ;
Williamson, Paula R. ;
Chadwick, David W. ;
Park, B. Kevin ;
Pirmohamed, Munir .
PHARMACOGENOMICS, 2006, 7 (06) :813-818
[4]   Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization [J].
Altmaee, Signe ;
Haller, Kadri ;
Peters, Maire ;
Hovatta, Outi ;
Stavreus-Evers, Anneli ;
Karro, Helle ;
Metspalu, Andres ;
Salumets, Andres .
MOLECULAR HUMAN REPRODUCTION, 2007, 13 (7-8) :521-526
[5]  
American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776
[6]  
ANDERSON ABM, 1977, OBSTET GYNECOL, V49, P471
[7]   Amoxicillin pharmacokinetics in pregnant women: Modeling and simulations of dosage strategies [J].
Andrew, M. A. ;
Easterling, T. R. ;
Carr, D. B. ;
Shen, D. ;
Buchanan, M. L. ;
Rutherford, T. ;
Bennett, R. ;
Vicini, P. ;
Hebert, M. F. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :547-556
[8]  
[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A
[9]  
[Anonymous], 2000, Cochrane Database Syst Rev., DOI DOI 10.1002/14651858.CD000065
[10]   Dexamethasone-induced prenatal alveolar wall thinning is associated with a decrease in EIIIA+ fibronectin isoform in the fetal rat lung [J].
Arai, H ;
Kikuchi, W ;
Ishida, A ;
Takada, G .
BIOLOGY OF THE NEONATE, 2005, 87 (02) :113-120